Feline Astrovirus

Overview and Taxonomy of Feline Astrovirus

Feline astrovirus (FAstV), also referred to in the literature as FeAstV, represents a significant and increasingly recognized enteric pathogen within the family Astroviridae. These viruses are small, non-enveloped, icosahedral particles possessing a positive-sense, single-stranded RNA genome, typically ranging from 6.4 to 7.3 kb in length [6, 13, 15]. The virion structure is defined by a capsid protein shell that undergoes extensive proteolytic processing, a critical maturation step that governs cellular localization, structural integrity, and infectivity [16]. The genomic organization of FAstV is characteristic of the family, comprising three overlapping open reading frames (ORFs): ORF1a, ORF1b, and ORF2 [6, 13]. ORF1a and ORF1b encode the non-structural proteins, including the viral protease and the RNA-dependent RNA polymerase (RdRp), respectively, while ORF2 encodes the capsid protein precursor, which is the primary determinant of antigenicity and host specificity [4, 16]. A ribosomal frameshift mechanism between ORF1a and ORF1b is essential for the expression of the viral polymerase [15].

Discovery and Initial Classification

The first identification of astrovirus-like particles in domestic cats was reported in 1981 in the United States, visualized by electron microscopy in the feces of kittens suffering from diarrhea [4, 14]. This initial observation placed FAstV within the genus Mamastrovirus, a taxonomic assignment that has been consistently upheld by subsequent molecular and phylogenetic analyses [4, 11]. The genus Mamastrovirus encompasses astroviruses infecting a wide range of mammalian hosts, including humans, cattle, swine, dogs, and numerous other species, and is distinct from the genus Avastrovirus, which infects avian hosts [11, 15]. For decades, the study of FAstV lagged behind that of other enteric feline pathogens, but the advent of sensitive molecular diagnostic techniques and metagenomic sequencing has dramatically accelerated our understanding of its diversity, prevalence, and global distribution [4, 13].

Genomic Architecture and Phylogenetic Framework

The complete genome of a feline astrovirus, strain FAstV2 1637F from a domestic cat in Hong Kong, was first reported in 2013, confirming the 6,779-nucleotide genome structure with the canonical three ORFs [6]. This landmark study also revealed that this particular strain was closely related to human astroviruses, hinting at the complex evolutionary history and potential for cross-species transmission within the genus [6, 15]. Subsequent phylogenetic analyses, particularly those based on the highly variable ORF2 capsid gene, have become the cornerstone for classifying FAstV diversity [1, 4, 8, 9]. The capsid protein is the primary target for neutralizing antibodies and is under significant selective pressure, leading to the emergence of distinct genetic lineages [16].

Genetic Diversity and the Challenge of Classification

A major advance in FAstV taxonomy came from large-scale molecular epidemiological studies, particularly in China, which have revealed a remarkable degree of genetic heterogeneity. Yi et al. (2018) provided the first molecular evidence of FAstV circulation in mainland China, analyzing complete capsid genes from strains in northeast China [4]. Their phylogenetic analysis demonstrated that all identified strains clustered into two distinct groups, with a mean amino acid genetic distance of 0.454 ± 0.016 between them. This level of divergence is substantial and, according to the species demarcation criteria for the Astroviridae family, strongly supports the classification of these groups as separate genotype species [4]. This foundational work established that FAstV is not a monotypic entity but rather a complex of genetically diverse viruses.

More recent and comprehensive investigations have expanded this framework. Xue et al. (2025), in a study of 775 feline intestinal samples from Guangxi, China, performed phylogenetic analysis on 13 ORF2 genes and two complete genomes [1]. Their work identified three distinct FAstV genogroups (designated G1, G2, and G3), with significant amino acid p-distances ranging from 0.445 to 0.765 between groups [1]. This three-group classification is now emerging as a robust model for understanding FAstV diversity. The genetic distance between these groups is comparable to or even exceeds that observed between established species of astroviruses in other hosts, reinforcing the argument that these genogroups represent distinct viral species within the feline host [1, 4].

Further complicating the taxonomic picture is the discovery of novel astroviruses that are phylogenetically distinct from the previously recognized groups. Using metagenomic next-generation sequencing, Brussel et al. (2020) identified two novel feline astroviruses, termed Feline astrovirus 3 and 4 (FAstV-3 and FAstV-4), from shelter-housed kittens in Australia [13]. These viruses were found to be phylogenetically distinct from all previously characterized feline astroviruses based on concatenated ORF and capsid protein analyses [13]. This discovery underscores that the full extent of FAstV genetic diversity is far from cataloged and that the current classification system may need to be expanded to accommodate these novel lineages. The precise evolutionary history of these novel viruses remains unclear due to a lack of resolution at key phylogenetic nodes, suggesting complex evolutionary processes, including potential recombination events [13, 15].

Epidemiological Context and Clinical Associations

The genetic diversity of FAstV is mirrored by its widespread geographical distribution and variable prevalence. Since its initial detection, FAstV has been reported in domestic cat populations across the globe, including the United States, Japan, Thailand, Italy, Australia, and extensively throughout China [1, 4, 7-9, 13]. Prevalence rates vary significantly depending on the diagnostic method used, the population sampled (e.g., healthy vs. diarrheic cats), and the geographical region. Studies employing sensitive real-time RT-PCR assays have reported overall prevalence rates ranging from approximately 4.25% to 23.4% in China [1, 3-5]. In Japan, a study of cats with gastrointestinal symptoms found a detection rate of 27.8% in kittens under one year of age, with a notable seasonal peak in winter (44.4%) [9]. In Thailand, a recent survey of 636 domestic cats reported a 10.8% positivity rate for FeAstV [8].

Critically, a consistent and robust association has been established between FAstV infection and diarrheal illness. Dong et al. (2021) demonstrated a significantly higher positive rate in cats with diarrhea (32.26%) compared to asymptomatic cats (7.58%) using a highly sensitive TaqMan qPCR assay [3]. Similarly, Yi et al. (2018) found a prevalence of 36.2% in diarrheic cats versus 8.7% in asymptomatic cats [4]. An outbreak investigation in an animal shelter in the United States provided compelling evidence for a causal role, demonstrating that 91% of sick cats with vomiting were shedding FAstV, while the virus was absent in samples collected from the same shelter one year before and after the outbreak [7]. This study strongly suggests that FAstV can act as a primary pathogen in outbreaks of contagious feline vomiting and is not merely a component of the commensal virome [7]. Experimental inoculation of specific-pathogen-free cats with a recent FAstV isolate has provided the first direct evidence of virus-induced diarrhea, with one of four inoculated cats developing self-limiting diarrhea and all animals showing seroconversion [2].

Evolutionary Dynamics and Cross-Species Transmission Potential

Astroviruses are characterized by high genetic variability, driven by an error-prone RNA-dependent RNA polymerase and frequent recombination events between strains [15]. This evolutionary plasticity is a key factor in their ability to emerge in new hosts and adapt to changing environments. Recombination, in particular, can lead to drastic evolutionary changes and has been implicated in cross-species transmission events [15]. The close phylogenetic relationship between some FAstV strains and human astroviruses, as noted in the initial genome characterization of FAstV2 [6], raises important questions about the potential for zoonotic transmission. While definitive evidence for zoonotic FAstV infection in humans is lacking, the genetic similarity is concerning, and the detection of astrovirus strains in environmental waters that suggest recombination between human and feline astroviruses highlights the potential for such events to occur [12]. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) recognize the importance of monitoring emerging zoonotic pathogens, and the continued surveillance of astroviruses in both domestic and wild animal populations is a critical component of pandemic preparedness. The detection of FAstV in bobcats (Lynx rufus) at the wildland-urban interface further underscores the potential for cross-species transmission between domestic and wild felids, facilitated by factors such as urbanization and host genetic relatedness [10]. This complex interplay of high genetic diversity, frequent recombination, and potential for interspecies transmission makes FAstV a compelling model for studying viral emergence and a pathogen of significant concern for both feline and potentially public health.

Genetic Diversity and Phylogenetic Classification

The family Astroviridae comprises small, non-enveloped, positive-sense, single-stranded RNA viruses that exhibit a remarkable capacity for genetic variation, driven by an error-prone RNA-dependent RNA polymerase (RdRp) and frequent recombination events [15]. Within this family, the genus Mamastrovirus encompasses a diverse array of viruses infecting mammalian hosts, including humans, swine, canines, and felines. Feline astrovirus (FAstV), while recognized for decades, has only recently been subjected to intensive molecular scrutiny, revealing a complex and dynamic genetic landscape that challenges traditional classification paradigms and necessitates a refined understanding of its evolutionary biology.

Taxonomy and the Genus Mamastrovirus

Feline astroviruses are classified within the species Mamastrovirus 2, a taxonomic grouping that also includes porcine astroviruses and certain human astrovirus genotypes, reflecting a close evolutionary relationship underscored by inter-species transmission potential [2, 7, 9]. This species designation, however, masks considerable underlying genetic heterogeneity. Early classification efforts, primarily based on partial RdRp sequences and complete capsid (ORF2) gene analysis, identified two major genogroups, tentatively designated group 1 and group 2, circulating in domestic cat populations [4]. Subsequent large-scale molecular epidemiological investigations, particularly from China, have expanded this framework, demonstrating the existence of at least three distinct genogroups (G1, G2, and G3) with profound sequence divergence [1]. The precise evolutionary relationships between these groups remain a subject of active investigation, as the lack of robust phylogenetic resolution at key nodes suggests a complex history of ancient divergence and potential recombination [13].

Genetic Markers and Phylogenetic Framework

The genetic characterization of FAstV relies heavily on two principal genomic regions: the ORF1b gene, encoding the viral RNA-dependent RNA polymerase (RdRp), and the ORF2 gene, encoding the capsid protein. The RdRp, while relatively conserved across the family Astroviridae, provides sufficient variability for genus-level and intra-species differentiation. Indeed, early phylogenetic analyses of FAstV were predicated on partial RdRp sequences, which confirmed the clustering of feline viruses within the genus Mamastrovirus [11]. However, the ORF2 gene has emerged as the primary target for high-resolution genotyping and classification, as it exhibits substantially higher genetic diversity, reflecting selective pressures from the host immune system and functional constraints on receptor binding and viral entry [11, 16]. The capsid protein is the principal antigenic determinant and mediates critical steps in the viral life cycle, including host cell attachment, endocytosis, and genome release, making it the logical target for phylogenetic inference [16].

Phylogenetic analyses spanning multiple geographic regions, including China [1, 3, 4], Japan [9], Thailand [8], and Hong Kong [6], consistently demonstrate the circulation of FAstV strains that cluster into distinct lineages. Studies from Northeast China initially delineated two major groups based on complete ORF2 sequences, with a mean amino acid genetic distance of 0.454 ± 0.016 between them [4]. This value, exceeding 0.45, aligns with the species demarcation criteria established for other mamastroviruses and strongly supports the classification of these groups as separate genotypes [4]. More recent work from Guangxi, China, has further refined this taxonomy, identifying three divergent genogroups (G1–G3) with amino acid p-distances ranging from 0.445 to 0.765, providing compelling evidence for the existence of at least three distinct FAstV genotypes [1]. The G1 lineage, corresponding to Mamastrovirus 2, appears to be the most prevalent and widely distributed, encompassing the overwhelming majority of strains recovered from clinical samples worldwide [2, 8, 9].

Genogroup Diversity and Molecular Demarcation

The genetic distance observed between FAstV genogroups is not merely a taxonomic curiosity; it has profound implications for diagnostic assay design, vaccine development, and our understanding of viral pathogenesis. The mean amino acid p-distance of 0.454 ± 0.016 between groups 1 and 2, as reported by Yi et al. (2018) [4], is comparable to the genetic divergence separating established astrovirus species, such as human astrovirus genotypes. The subsequent identification of a third genogroup (G3) by Xue et al. (2025) [1], with similar divergence values (0.445–0.765), underscores the continued discovery of novel genetic diversity within feline populations. This suggests that FAstV may comprise a constellation of genetically distinct viral entities that have evolved in isolation or under distinct selective pressures, potentially reflecting adaptation to different feline host populations or ecological niches.

The complete genome sequences of representative strains from these groups provide critical insights into their evolutionary history. The first complete genome of a novel FAstV genotype, FAstV2 strain 1637F from Hong Kong, was 6,779 nucleotides in length and exhibited a close phylogenetic relationship with human astroviruses, hinting at possible ancestral cross-species transmission events [6]. Subsequent metagenomic analyses have identified even more divergent feline astroviruses, designated FAstV-3 and FAstV-4, which are phylogenetically distinct from previously characterized strains and whose evolutionary history cannot be resolved with current data [13]. This underscores the likelihood that the full extent of FAstV genetic diversity has not yet been captured, and that additional, potentially highly divergent lineages await discovery in under-sampled feline populations, particularly in free-roaming and wild felid species. The detection of FAstV in bobcats (Lynx rufus) at the wildland–urban interface further emphasizes the role of cross-species transmission and the potential for viral spillover between domestic and wild felids, adding a layer of complexity to the evolutionary dynamics of this virus [10].

Novel Genotypes and Recombination

Beyond the established genogroups, the astrovirus family is characterized by a high frequency of recombination, which can generate drastic evolutionary changes and facilitate cross-species transmission [15]. Recombination events, particularly within the capsid gene, have been documented for human and porcine astroviruses, and there is emerging evidence for such events involving FAstV. Next-generation amplicon sequencing of environmental water samples has detected putative recombinants between human and feline astroviruses, suggesting that genetic exchange may occur in environments where both human and animal waste are present [12]. This has significant implications for viral emergence, as recombinant viruses may possess novel antigenic properties or altered host tropisms. While robust recombination analyses for FAstV are still limited, the detection of highly divergent strains such as FAstV-3 and FAstV-4, whose phylogenetic positions are ambiguous, raises the possibility that these viruses arose from ancient recombination events [13].

The use of advanced molecular techniques, including metagenomic next-generation sequencing and amplicon-based deep sequencing, has been instrumental in uncovering this hidden diversity. These methods are capable of detecting multiple, genetically distinct viral populations within a single sample, revealing the co-circulation of different FAstV genotypes within the same geographic region and even within individual animals [12, 13]. This intra-host viral diversity has important implications for disease pathogenesis and the potential for rapid viral evolution under selective pressure from the host immune system.

Implications for Pathogenesis and Surveillance

The genetic diversity of FAstV is inextricably linked to its epidemiology and clinical presentation. While FAstV infection is frequently associated with mild, self-limiting gastroenteritis, particularly in young kittens, the role of specific genotypes in disease severity remains poorly defined [2, 14]. Co-infection with other enteric pathogens, most notably feline parvovirus (FPV), is exceptionally common, with studies reporting co-infection rates exceeding 39% in FAstV-positive cats [1, 2, 18]. This frequent co-occurrence suggests a potential synergistic interaction, where FAstV infection may exacerbate the pathology of FPV, or vice versa. Indeed, experimental co-infection studies have demonstrated enhanced FAstV replication in the presence of FPV, providing a mechanistic basis for this epidemiological observation [2]. The genetic identity of the infecting FAstV strain could modulate this interaction; certain genotypes may possess enhanced replication kinetics or broader tissue tropism, predisposing to more severe disease when acting in concert with other pathogens.

The high genetic distance between genogroups also poses a significant challenge for molecular diagnostics. Most PCR-based assays, including conventional and real-time RT-PCR methods, target conserved regions of the RdRp gene (ORF1b) to ensure broad detection of diverse strains [3-5, 18]. However, the degree of sequence variation in the ORF2 gene can be so extensive that detection of all known genotypes with a single primer-probe set may not be feasible [1, 4]. The development of multiplex assays for the simultaneous detection of FAstV alongside other feline enteric viruses, such as FPV, feline bocavirus (FBoV), and feline kobuvirus (FeKoV), is therefore essential for comprehensive clinical diagnostics [17-19]. The ongoing discovery of novel FAstV genotypes necessitates continuous monitoring and periodic re-evaluation of diagnostic assays to ensure they remain fit for purpose.

From a global perspective, the genetic diversity of FAstV appears to be geographically structured, although the increasing volume of sequence data from Asia, Europe, and North America suggests a cosmopolitan distribution of the major genogroups. Strains from China, Japan, Thailand, and Hong Kong have all been classified within Mamastrovirus 2, group 1, indicating that this lineage is globally dominant [1, 8, 9]. However, the unique genotypes from China (G2 and G3) and the novel FAstV-3 and FAstV-4 from Australia [13] suggest that regional endemic lineages may exist, possibly reflecting founder effects or local adaptation. Large-scale, prospective surveillance studies employing standardized genotyping methods are urgently needed to map the global distribution of FAstV genotypes, track their emergence and spread, and assess their zoonotic potential, given the close genetic relationship between some FAstV strains and human astroviruses [6, 12]. The Office International des Epizooties (WOAH) recognizes astroviruses as emerging pathogens of concern in both domestic and wild animals, underscoring the importance of continued molecular surveillance [10, 15].

Molecular Pathogenesis and Viral Replication

Genomic Organization and Phylogenetic Framework

Feline astrovirus (FAstV) belongs to the genus Mamastrovirus within the family Astroviridae, a lineage of non-enveloped, positive-sense, single-stranded RNA viruses that infect a remarkably broad range of mammalian and avian hosts [1, 15]. The canonical FAstV genome is approximately 6.8 kb in length, organized into three overlapping open reading frames (ORFs): ORF1a, ORF1b, and ORF2. The first complete genome sequence of a feline astrovirus, FAstV2 strain 1637F from Hong Kong, confirmed this architectural paradigm and demonstrated that ORF1a and ORF1b encode the nonstructural polyproteins, including the viral protease and the RNA-dependent RNA polymerase (RdRp), while ORF2 encodes the structural capsid protein [6]. This fundamental genomic blueprint is conserved across all FAstV genogroups, although ORF2 exhibits extraordinary sequence variability that underpins the genotypic diversity observed globally [1, 4, 13].

Phylogenetic analyses based on complete capsid sequences have consistently delineated FAstV strains into distinct genogroups. Early molecular characterization in northeast China revealed two major groups with a mean amino acid genetic distance of 0.454 ± 0.016, a divergence sufficient to warrant classification as separate genotype species [4]. Subsequent large-scale surveillance in Guangxi, China, employing 13 ORF2 genes and two complete genomes, identified three distinct FAstV genogroups (G1–G3) with highly significant amino acid p-distances ranging from 0.445 to 0.765, firmly establishing the existence of multiple genotypes within feline populations [1]. Molecular epidemiological investigations in Thailand further refined this landscape, demonstrating that circulating Thai-FeAstV strains all clustered within FeAstV group 1, aligning with the most prevalent lineage observed globally [8]. Critically, metagenomic next-generation sequencing of fecal samples from shelter-housed kittens has uncovered two additional phylogenetically distinct astroviruses, provisionally designated Feline astrovirus 3 and 4, which possess the characteristic tripartite ORF arrangement but occupy independent evolutionary branches whose precise relationships remain unresolved due to insufficient nodal resolution [13]. This expanding genetic repertoire underscores the dynamic evolutionary processes driving FAstV diversification.

Structural Biology of the Capsid and Proteolytic Maturation

The astrovirus capsid protein (CP) is the primary determinant of host tropism, receptor engagement, and immunogenicity. As comprehensively reviewed by Arias and DuBois, the astrovirus capsid undergoes a highly coordinated proteolytic maturation cascade that is essential for infectivity [16]. The full-length capsid precursor, encoded by ORF2, is synthesized as a ~79–87 kDa polypeptide that is subject to intracellular cleavage by the viral serine protease encoded within ORF1a, generating an N-terminal core domain (VP34 or analogous species) and a C-terminal spike domain. This initial processing event is critical for capsid assembly and the acquisition of icosahedral symmetry. Following virion release from the host cell, extracellular trypsin-like proteases in the gastrointestinal tract, derived from the host pancreas or resident microbiota, cleave the spike domain into smaller polypeptides (VP25 and VP27), a step that dramatically enhances viral entry and uncoating [16]. The absolute requirement for trypsin supplementation for successful FAstV isolation in cell culture, as demonstrated by Xue et al. who isolated strain GXNNF10-2024 in FK81 cells only in trypsin-supplemented media, directly reflects this dependence on extracellular proteolytic processing for gain of infectivity [1]. Similarly, Wang et al. successfully adapted a FAstV strain (22SDWH1003-16) to growth in F81 cells over fifteen passages in the presence of trypsin, with characteristic cytopathic effects (CPEs) emerging only under these conditions [2]. These observations collectively indicate that FAstV, like other mamastroviruses, requires proteolytic priming of its capsid to facilitate receptor binding and membrane penetration.

The capsid protein also serves as a central hub for host immune evasion. The astrovirus CP binds directly to components of the complement system, including C1q, thereby inhibiting the classical pathway of complement activation [16]. This mechanism allows the virus to persist in the face of humoral immune responses and likely contributes to the prolonged fecal shedding observed in both experimentally and naturally infected cats. Furthermore, the capsid is the primary target of neutralizing antibodies, and the hypervariable regions within ORF2, particularly in the surface-exposed spike domain, are subject to intense positive selection pressure, driving antigenic drift and enabling the circulation of multiple genotypes within feline populations [4, 9].

Replicative Cycle and Host Cell Interactions

The replication cycle of FAstV follows the canonical astrovirus strategy, yet species-specific adaptations shape its pathogenesis in feline hosts. The initial step, virus attachment, is mediated by the mature capsid spike domain, which binds to undefined glycan receptors on the apical surface of differentiated enterocytes. Viral entry occurs via clathrin-mediated endocytosis, followed by acid-dependent uncoating within endosomal compartments [16]. The positive-sense RNA genome is released into the cytoplasm and immediately serves as mRNA for ORF1a translation. The ORF1a polyprotein contains a serine protease domain and a viral genome-linked protein (VPg) that is covalently attached to the 5' end of the genomic RNA and facilitates cap-independent translation. Translational readthrough or a ribosomal frameshifting event at the junction of ORF1a and ORF1b generates the ORF1a-ORF1b fusion polyprotein, which is subsequently processed by the viral protease to liberate the RdRp [15, 22]. This noncanonical expression mechanism is a hallmark of astrovirus replication and ensures precise stoichiometric regulation of replication complex components.

The viral RdRp orchestrates genome replication through a negative-sense intermediate, generating multiple positive-sense progeny genomes that serve as templates for further translation and packaging. Astrovirus RdRps are inherently error-prone, lacking proofreading exonuclease activity, which results in a high mutation rate estimated at 10⁻³ to 10⁻⁵ substitutions per site per year [15]. This genetic plasticity fuels rapid adaptation to host immune pressure and facilitates the emergence of novel genotypes. Critically, recombination events between co-infecting astrovirus strains, including inter-species recombination between human and feline astroviruses, have been documented in environmental water samples, indicating that the RdRp can undergo template switching during replication [12]. Such recombination can create chimeric genomes with altered capsid properties, potentially expanding host range or enhancing fitness. Co-infection of cats with multiple FAstV genotypes, as commonly observed in epidemiological surveys [1, 2, 4], provides the necessary substrate for these recombinational events to occur.

Viral Shedding and Pathogenesis in the Feline Host

The molecular pathogenesis of FAstV is intimately linked to its tropism for the gastrointestinal epithelium. Following oral ingestion, the virus withstands the acidic gastric environment and, after trypsin-mediated capsid activation, infects mature enterocytes lining the small and large intestines [22]. Viral replication induces apoptosis and sloughing of infected cells, leading to villous blunting, crypt hyperplasia, and disruption of the intestinal epithelial barrier. These histopathological changes manifest clinically as self-limiting diarrhea, with experimental inoculation of specific-pathogen-free cats resulting in seroconversion in all animals, transient fecal shedding in 75% (3/4) of cats, and mild, self-limiting diarrhea in one individual [2]. The high prevalence of FAstV in diarrheic versus asymptomatic cats, 32.26% versus 7.58% in one large-scale Chinese study [3], provides robust statistical evidence for the causative role of FAstV in feline gastroenteritis.

FAstV infection elicits a robust but transient local immune response. Histological examination of intestinal tissues from infected cats reveals infiltration of lymphocytes and macrophages into the lamina propria, accompanied by upregulation of pro-inflammatory cytokines including IL-6 and TNF-α. Interestingly, astrovirus nonstructural proteins have been shown to antagonize the interferon response through the degradation of key signaling molecules, allowing the virus to replicate efficiently despite the host's innate antiviral defenses [22]. This immune evasion may account for the prolonged shedding observed in naturally infected cats, with longitudinal monitoring documenting fecal excretion lasting up to 19 days in shelter outbreaks [7]. The virus can be shed at high concentrations even in the feces of clinically normal cats, suggesting that subclinical carriers serve as important reservoirs for environmental contamination and transmission [14].

The Role of Co-Infection in Modulating Pathogenesis

A defining feature of FAstV molecular epidemiology is its frequent occurrence as part of polymicrobial enteric infections. Comprehensive surveillance in Guangxi, China, revealed that 39.4% (13/33) of FAstV-positive feline intestinal samples were co-infected with at least one of six other major feline enteric viruses, with FAstV-feline panleukopenia virus (FPV) co-infection being the most prevalent combination, accounting for 27.27% of all positive cases [1]. This pattern is consistent across multiple geographic regions: in northeast China, co-infection with FPV, feline bocavirus (FBoV), and feline kobuvirus (FeKoV) was documented in 38 of 46 FAstV-positive samples [4]. Similarly, a study from eastern Shandong reported that FAstV co-infections in parvovirus-positive cats accounted for a substantial proportion of cases [20], while investigations in Japan found FAstV detection rates significantly higher in winter (44.4%) and in cats under one year of age (27.8%), demographics that overlap with periods of high FPV incidence [9].

The molecular mechanisms underlying these synergistic interactions are beginning to be elucidated. Wang et al. demonstrated through controlled co-infection experiments that the presence of FPV significantly enhances FAstV replication in vivo, with co-infected cats exhibiting higher viral loads and more prolonged shedding compared to cats infected with FAstV alone [2]. Parvovirus-induced immunosuppression, particularly the depletion of lymphoid cells in the gut-associated lymphoid tissue (GALT), likely creates a permissive environment for astrovirus expansion by attenuating the antiviral interferon response. Additionally, the destruction of intestinal epithelial cells by FPV may expose deeper cellular layers, facilitating FAstV access to a larger target cell population. This mutualistic interaction may explain the increased severity of clinical gastroenteritis observed in co-infected cats, as reflected in the higher FAstV prevalence, 36.2% versus 8.7%, in diarrheic compared to asymptomatic cats across multiple studies [3, 4].

Inter-Species Transmission and Zoonotic Potential

The Astroviridae family has historically been considered highly species-specific, but accumulating evidence challenges this paradigm. Feline astroviruses cluster phylogenetically within the Mamastrovirus 2 species, which also contains human astrovirus genotypes 4–8, suggesting a shared evolutionary ancestry and potential for cross-species transmission [11, 15]. Indeed, recombination between human and feline astroviruses has been identified in environmental water samples using next-generation amplicon sequencing, indicating that these viruses can exchange genetic material in co-infected hosts or contaminated environments [12]. Furthermore, detection of feline astrovirus in bobcats (Lynx rufus) at the wildland–urban interface demonstrates that this virus can circulate among wild felids and may serve as a bridge for transmission between domestic and sylvatic cycles [10]. The presence of FAstV in environmental samples also raises questions about its stability and persistence in water, highlighting the need for surveillance of this pathogen in wastewater and surface waters, much as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) monitor enteric viruses in water safety programs for human health [12, 21].

The genetic plasticity of astrovirus replication, driven by the error-prone RNA-dependent RNA polymerase and frequent recombination, positions FAstV as a potential emerging zoonotic threat, although no direct human infections from feline strains have been conclusively documented to date [15, 21]. The capsid receptor-binding properties likely impose species barriers that restrict cross-species transmission, but the dynamic nature of astrovirus evolution, as illustrated by the rapid emergence of novel human astrovirus clades (MLB and VA) associated with extra-intestinal disease, warrants continued vigilance. The World Organisation for Animal Health (WOAH) has recognized the importance of monitoring astrovirus diversity in domestic animals as part of a One Health approach to emerging infectious diseases.

Conclusion of Molecular Mechanisms

In summary, the molecular pathogenesis of FAstV is orchestrated by a compact RNA genome encoding a structurally versatile capsid that requires proteolytic activation for infectivity, an error-prone RdRp that generates substantial genetic diversity, and a replication strategy that targets intestinal epithelial cells while evading innate immune responses. The virus exists as multiple genogroups with high capsid divergence, enabling persistent circulation in feline populations. Co-infection with other enteric pathogens, particularly FPV, potentiates FAstV replication and disease severity through immune modulation and tissue damage. This intricate interplay between viral genetics, host factors, and the polymicrobial enteric environment defines the clinical spectrum of FAstV infection, ranging from asymptomatic shedding to acute gastroenteritis. The ongoing discovery of novel FAstV genotypes and the demonstration of inter-species recombination underscore the need for continued molecular surveillance to anticipate potential shifts in host range and pathogenicity.

Epidemiology and Risk Factors in Domestic Cats

Feline astrovirus (FeAstV) has emerged as a globally distributed enteric pathogen of domestic cats, with prevalence rates that vary markedly by geographic region, diagnostic methodology, clinical status of the studied population, and demographic factors including age and season. Understanding the epidemiological landscape of FeAstV infection is essential for developing effective surveillance strategies, elucidating transmission dynamics, and assessing the clinical significance of this increasingly recognized viral agent. The cumulative evidence from molecular epidemiological investigations across multiple continents over the past decade has revealed that FeAstV circulates widely in domestic cat populations, frequently in conjunction with other enteric pathogens, and demonstrates substantial genetic diversity that complicates both diagnosis and our understanding of its pathogenic potential.

Global Prevalence and Geographic Distribution

The prevalence of FeAstV in domestic cats has been documented across diverse geographic settings, with reported rates ranging from approximately 4% to over 36% depending on the population studied and the diagnostic sensitivity employed. The earliest molecular epidemiological investigation in mainland China, conducted by Yi et al. in northeast China, detected FeAstV in 23.4% (46/197) of fecal samples tested by RT-PCR targeting the RNA-dependent RNA polymerase (RdRp) gene, with a striking disparity between diarrheic cats (36.2%, 38/105) and asymptomatic individuals (8.7%, 8/92) [4]. This seminal study established that FeAstV was not only circulating in the region but was significantly associated with clinical disease. Subsequent investigations employing more sensitive real-time PCR methodologies have corroborated these findings; Dong et al. utilized a TaqMan-based quantitative PCR assay with a detection limit of 3.52 copies/μL to screen 578 clinical fecal samples from northeast China, revealing an overall prevalence of 18.17% (105/578), with rates of 32.26% (80/248) in diarrheic cats and 7.58% (25/330) in asymptomatic cats [3]. The enhanced sensitivity of real-time PCR over conventional RT-PCR has been repeatedly demonstrated; Wang et al. reported that SYBR Green I-based real-time RT-PCR was 100-fold more sensitive than conventional methods, detecting as few as 3.72 × 10¹ copies/μL [5], suggesting that earlier studies employing less sensitive techniques may have underestimated true prevalence.

In southern China, Xue et al. screened 775 feline intestinal samples from Guangxi province and identified an FeAstV prevalence of 4.25% (33/775) using conventional detection methods [1]. This markedly lower rate compared to studies in northeast China likely reflects both geographic variation in viral circulation and differences in the sampled populations, as well as the diagnostic platforms employed. A larger-scale investigation in Guangxi using a quadruplex RT-qPCR assay developed by Shi et al. tested 1,869 clinical samples and reported an FeAstV positivity rate of 9.36% [17], substantially higher than the 4.25% detected by Xue et al. in the same province. The quadruplex assay demonstrated limits of detection of 115.834 copies/reaction for FeAstV, with 100% specificity and excellent reproducibility (intra- and inter-assay coefficients of variation of 0.15–1.61% and 0.15–1.59%, respectively) [17]. The discrepancy between these two Guangxi studies underscores the critical importance of diagnostic methodology in determining apparent prevalence, with multiplex molecular assays increasingly replacing conventional single-target PCR for routine surveillance.

Beyond China, FeAstV has been documented across Asia, Europe, North America, and Australia. In Thailand, Thaw et al. conducted a prospective survey from January 2022 to December 2023, testing 636 rectal swabs from domestic cats at private small animal hospitals in Bangkok, Nonthaburi, and Samut Prakran, detecting FeAstV in 10.8% (69/636) of samples [8]. This represents the first molecular characterization of FeAstV in Thailand and confirms the virus’s presence in Southeast Asia. In Japan, Soma et al. examined feces from 204 domestic cats with gastrointestinal symptoms and reported a FeAstV detection rate of 44.4% during winter months, with significant seasonal variation [9]. Historical data from Australia, derived from electron microscopic examination of feline fecal samples collected between 1984 and 1985, identified astrovirus particles in 7% of 208 shelter cats, providing early evidence of viral circulation predating the molecular era [14]. More recently, metagenomic next-generation sequencing approaches have expanded our understanding of FeAstV diversity; Brussel et al. identified two novel feline astroviruses (termed Feline astrovirus 3 and 4) from shelter-housed kittens in Australia, demonstrating that viral diversity exceeds that captured by conventional PCR-based surveillance alone [13].

Risk Factors: Age, Season, and Clinical Status

Age has emerged as a consistent risk factor for FeAstV infection across multiple studies. Soma et al. demonstrated significantly higher detection rates in cats under one year of age (27.8%) compared to older individuals (12.4%), with statistical significance (P < 0.05) [9]. This age-associated susceptibility aligns with the epidemiology of astrovirus infections in other species, including humans, where young individuals typically exhibit increased vulnerability to infection and disease. The biological basis for this age predisposition likely involves the immaturity of the neonatal immune system, particularly the delayed development of effective mucosal immune responses, combined with the waning of maternally derived antibodies that typically occurs between 6 and 16 weeks of age. In kittens, the transition from passive to active immunity creates a window of susceptibility that coincides with the period of highest astrovirus prevalence. Additionally, behavioral factors, including increased exploratory oral behaviors, higher frequency of social contact in multi-cat environments, and incomplete litter box training, may contribute to enhanced exposure risk in juvenile cats.

Seasonal variation in FeAstV prevalence has been documented, with significant implications for understanding transmission dynamics. Soma et al. reported that FeAstV detection rates were significantly higher in winter (44.4%) than in other seasons in Japan [9], a pattern that has been observed for astroviruses in other mammalian hosts, including humans, where astrovirus gastroenteritis classically peaks during cooler months in temperate climates [21]. The mechanistic basis for this seasonality remains incompletely understood but may involve environmental factors such as increased indoor crowding during cold weather, enhanced viral stability at lower temperatures, and potential seasonal fluctuations in host immune competence. Environmental water surveillance studies have similarly demonstrated that classical human astroviruses are more prevalent during cooler months, while divergent clades may exhibit different seasonal patterns [12]. It is noteworthy that Soma et al. found no significant seasonal variation for concurrent feline parvovirus (FPV) infection in the same study population [9], suggesting that the winter peak is specific to FeAstV rather than reflecting generalized seasonal increases in enteric pathogen transmission.

The most robust and consistently replicated risk factor for FeAstV detection is the presence of clinical gastrointestinal disease, particularly diarrhea. The association between FeAstV and diarrhea has been demonstrated across multiple independent studies and geographic settings. In northeast China, Yi et al. found that 36.2% of diarrheic cats were FeAstV-positive compared to only 8.7% of asymptomatic cats [4], representing a more than four-fold increased odds of detection in clinically affected animals. Dong et al. confirmed this association using quantitative PCR, reporting a similar pattern with 32.26% positivity in diarrheic cats versus 7.58% in asymptomatic individuals [3]. The consistency of this association across different study designs, geographic regions, and diagnostic methodologies provides compelling epidemiological evidence for a pathogenic role of FeAstV in feline gastroenteritis. However, the detection of FeAstV in a substantial proportion of asymptomatic cats (7–9% in the aforementioned studies) indicates that subclinical infections are common, and the virus can be shed by apparently healthy individuals, potentially serving as reservoirs for transmission.

Experimental inoculation studies have provided direct evidence for FeAstV-induced disease. Wang et al. successfully isolated a FeAstV strain (22SDWH1003-16) in F81 cells and subsequently inoculated four specific-pathogen-free cats, demonstrating seroconversion in all animals, transient fecal shedding in 3/4 cats, and self-limiting diarrhea in one individual [2]. This experimental confirmation of pathogenicity, while preliminary, supports the epidemiological observations linking FeAstV to clinical gastroenteritis. Similarly, an outbreak investigation in an animal shelter by Li et al. documented a vomiting outbreak in cats where viral metagenomics identified FeAstV as the predominant agent; real-time RT-PCR on longitudinally acquired fecal samples showed that 10/11 sick cases (91%) were shedding astrovirus for up to 19 days, with affected cats sick for an average of 9.8 days [7]. Notably, 5/9 unaffected control cats (56%) housed in the same area during the outbreak were also shedding astrovirus, indicating that asymptomatic shedding is common even during outbreaks [7]. Samples collected from the same shelter approximately one year before and after the outbreak were all negative for FeAstV, strongly suggesting that the virus was temporarily associated with the clinical outbreak rather than being a component of the commensal virome [7].

Co-infection Dynamics and Synergistic Interactions

Co-infections with other enteric viruses are extremely common among FeAstV-positive cats and represent a critical factor influencing both the clinical presentation and the epidemiological patterns of infection. The frequency of co-infection ranges from 39.4% to over 82% of FeAstV-positive samples depending on the study, with feline parvovirus (FPV) consistently identified as the most frequently co-detected pathogen. Xue et al. reported that 39.4% (13/33) of FeAstV-positive cats in Guangxi were co-infected with at least one other major feline enteric virus, with FeAstV-FPV co-infection emerging as the predominant combination at 27.27% (9/33) [1]. This finding was echoed by Wang et al., who screened 86 feline diarrheal samples and found that most FeAstV-positive cases were co-infected with FPV [2]. Zhang et al. employed a multiplex PCR assay to screen 197 fecal samples from northeast China and detected FeAstV in 46 samples, FPV in 73, and feline bocavirus (FBoV) in 51, with mixed infections observed in 38 FeAstV-positive samples [18]. The high rate of co-infection raises important questions about the nature of viral interactions, whether these represent synergistic, antagonistic, or merely coincidental relationships.

The consistent predominance of FeAstV-FPV co-infection suggests a potential synergistic pathogenic interaction that may enhance the severity of clinical disease. Mechanistically, FPV is known to cause profound immunosuppression through its cytolytic effects on rapidly dividing cells, particularly lymphoid progenitors in the bone marrow and intestinal crypt epithelium. FPV-induced lymphopenia and impairment of both humoral and cell-mediated immune responses could create a permissive environment for enhanced FeAstV replication and prolonged viral shedding. Wang et al. directly tested this hypothesis through co-infection experiments and demonstrated enhanced FeAstV replication in the presence of FPV [2], providing experimental evidence for virological synergy. This interaction may contribute to the higher clinical severity observed in co-infected cats compared to those infected with either virus alone, and could explain the frequent detection of both viruses in outbreaks of severe gastroenteritis in shelters and multi-cat environments. Furthermore, the immunosuppressive effects of FPV may facilitate the emergence of novel FeAstV variants through increased replication and mutation, potentially contributing to the substantial genetic diversity observed in FeAstV populations.

Co-infections with other enteric viruses are also common. Yi et al. reported that FeAstV-positive cats were frequently co-infected with feline parvovirus, feline bocavirus, and feline kobuvirus (FeKoV) [4]. The development of multiplex diagnostic assays has greatly facilitated the simultaneous detection of multiple enteric pathogens. Zou et al. established a TaqMan-based multiplex real-time PCR for simultaneous detection of FBoV-1, FeAstV, FeKoV, and FPV, revealing a 25.19% (34/135) total rate of co-infection among clinical samples and a 1.48% (2/135) quadruple infection rate [23]. Similarly, Xiao et al. developed multiplex PCR methods for detecting feline respiratory and intestinal pathogens, including FeAstV alongside FCoV, FPV, FeKoV, FCV, FHV-1, FeLV, Chlamydia felis, and influenza A virus, further expanding our capacity to characterize the complex polymicrobial ecology of the feline enteric tract [19]. The high prevalence of polymicrobial infections challenges our ability to attribute clinical signs to any single etiological agent and suggests that disease pathogenesis may frequently involve multi-pathogen synergism.

Environmental and Management Factors

The epidemiological patterns of FeAstV infection suggest that environmental and management factors play important roles in transmission dynamics. The detection of FeAstV in shelter-housed cats at rates as high as 56% in asymptomatic individuals during an outbreak [7] underscores the potential for rapid spread in congregate housing settings where cats are housed in close proximity, share litter boxes and feeding stations, and may experience stress-induced immunosuppression that increases susceptibility to infection and shedding. The outbreak investigation by Li et al. demonstrated that FeAstV was temporarily associated with clinical disease and was not detected in the same shelter population one year before or after the outbreak [7], suggesting that the virus may circulate endemically in some facilities while causing sporadic outbreaks in others, possibly driven by factors such as cat population turnover, introduction of new animals, and seasonal effects.

The role of feral and free-roaming cats in FeAstV epidemiology deserves consideration. While most epidemiological studies have focused on owned or shelter-housed cats, the detection of feline astrovirus in wild felids, specifically bobcats (Lynx rufus) at the wildland-urban interface in Arizona [10], suggests that FeAstV may circulate in non-domestic felid populations, potentially serving as reservoirs for spillover into domestic cats. Payne et al. identified FeAstV in scat samples from urban bobcats, alongside other feline and canine pathogens, and demonstrated that virome composition was shaped by host genetic relatedness and factors relating to urbanization, such as percentages of urban land cover, road and building densities, and distances to roads [10]. This finding highlights the potential for the wildland-urban interface to facilitate cross-species transmission and underscores the need for broader ecological surveillance to fully characterize FeAstV epidemiology.

Genetic Diversity and Epidemiological Implications

The genetic diversity of FeAstV has profound implications for its epidemiology, including its ability to emerge in new populations, evade immune detection, and potentially cross species barriers. Phylogenetic analyses based on the complete capsid gene have consistently identified multiple distinct genogroups circulating in domestic cat populations. Yi et al. performed the first comprehensive phylogenetic analysis of Chinese FeAstV strains, revealing that all isolates fell into two distinct groups with a mean amino acid genetic distance of 0.454 ± 0.016 between groups, supporting classification as separate genotype species [4]. Xue et al. extended this analysis, identifying three distinct FeAstV genogroups (G1-G3) among 13 ORF2 genes and 2 complete genomes from Guangxi, with significant amino acid divergence (0.445–0.765 p-distance) supporting their classification as separate genotypes [1]. The existence of multiple co-circulating genotypes within the same geographic region raises the possibility of differential pathogenesis, immune evasion, and recombination potential.

The role of recombination in astrovirus evolution is well-established and has significant epidemiological implications. Astroviruses possess high genetic variability due to an error-prone RNA-dependent RNA polymerase and frequent recombination events between strains, which can lead to drastic evolutionary changes and contribute to cross-species transmission events [15]. Recombination between human and feline astroviruses has been suggested based on analyses of environmental water samples [12], and the close genetic relationship between feline and human astrovirus strains has been noted since early genomic studies; Lau et al. reported that the first complete genome sequence of a feline astrovirus (FAstV2 strain 1637F from Hong Kong) was closely related to human astroviruses, suggesting a potential for interspecies transmission [6]. The genetic similarity between some human and animal astroviruses makes zoonotic transmission biologically plausible, although it has not been clearly recognized [21]. The identification of FeAstV in environmental water samples alongside human astroviruses [12] raises the possibility of indirect transmission through contaminated water sources, although the public health significance of this finding remains to be determined.

In conclusion, the epidemiology of FeAstV in domestic cats is characterized by wide geographic distribution, substantial genetic diversity, frequent co-infections with other enteric viruses, and strong associations with age, season, and clinical disease status. The development of increasingly sensitive molecular diagnostic tools has revealed that FeAstV is more prevalent than previously appreciated, and its role as a primary enteric pathogen is supported by both epidemiological association studies and experimental inoculation. The high rates of co-infection, particularly with FPV, suggest that FeAstV may act synergistically with other pathogens to cause disease, and the substantial genetic diversity of circulating strains presents challenges for both diagnosis and potential future vaccine development. Ongoing surveillance, particularly employing next-generation sequencing and metagenomic approaches, will be essential for monitoring viral evolution, detecting emerging variants, and understanding the full clinical and epidemiological significance of this ubiquitous feline enteric virus.

Clinical Manifestations and Co-infection Synergism

The clinical presentation of feline astrovirus (FAstV) infection is a complex and often subclinical phenomenon, yet mounting evidence firmly establishes its role as a significant enteric pathogen capable of inducing overt gastrointestinal disease, particularly in young, immunologically naïve, or co-infected cats. The spectrum of clinical manifestations ranges from asymptomatic shedding to severe, self-limiting gastroenteritis, with the severity and duration of disease frequently modulated by the presence of concurrent viral, bacterial, or parasitic pathogens. Understanding this clinical variability and the synergistic mechanisms underlying co-infection is paramount for accurate diagnosis, effective therapeutic intervention, and the development of robust control strategies in both shelter and household environments.

Clinical Spectrum of FAstV Infection

The clinical signs attributable to FAstV infection are predominantly gastrointestinal, reflecting the virus’s primary tropism for the intestinal epithelium. Affected cats, especially kittens, typically present with acute-onset diarrhea, which can vary in consistency from semi-formed to watery and may contain mucus or, less commonly, blood. Vomiting is a frequently reported clinical sign, and in some outbreak scenarios, it can be the predominant presenting complaint. A landmark investigation of an outbreak in an animal shelter demonstrated that feline astrovirus was the primary agent associated with contagious vomiting, with 91% of symptomatic cats shedding the virus, while 56% of unaffected controls were also shedding, highlighting a significant rate of asymptomatic infection [7]. Affected cats in this outbreak were sick for an average of 9.8 days, with a median of 2.5 days, though the range extended from 1 to 31 days, indicating substantial variability in disease duration [7]. Other common clinical manifestations include anorexia, lethargy, and dehydration, which can be particularly severe in young kittens, leading to significant morbidity if not managed supportively.

The association between FAstV and diarrhea has been robustly quantified in multiple epidemiological studies. A large-scale investigation in northeast China using a highly sensitive TaqMan qPCR assay found a significantly higher positive rate in cats with diarrhea (32.26%, 80/248) compared to asymptomatic cats (7.58%, 25/330), providing strong statistical evidence for the virus’s pathogenic potential [3]. Similarly, an earlier study in the same region reported an overall FAstV prevalence of 23.4% (46/197), with a striking 36.2% (38/105) in diarrheic cats versus only 8.7% (8/92) in asymptomatic individuals [4]. These data are corroborated by experimental inoculation studies, which have provided the most direct evidence of causality. In a controlled setting, specific-pathogen-free cats inoculated with a recently isolated FAstV strain developed seroconversion, transient fecal viral shedding in 3 out of 4 animals, and self-limiting diarrhea in one individual, definitively demonstrating that FAstV alone can induce clinical disease [2].

It is critical to recognize that FAstV infection is not uniformly pathogenic. A substantial proportion of infected cats, particularly adults, remain asymptomatic. This carrier state is epidemiologically significant, as these animals serve as a silent reservoir for viral shedding, perpetuating transmission within multi-cat environments. The factors that govern the transition from asymptomatic carriage to clinical disease are multifactorial and include host age (with kittens being disproportionately susceptible), immune status, viral load, and, most importantly, the presence of co-infecting pathogens. The virus’s ability to cause disease is also influenced by the specific genotype; while all three major genogroups (G1-G3) have been associated with enteric disease, differences in virulence and tissue tropism are likely, though not yet fully characterized [1, 4].

Co-infection Synergism: A Key Driver of Disease Severity

Perhaps the most clinically relevant aspect of FAstV infection is its frequent occurrence as part of a polymicrobial enteric infection. The concept of co-infection synergism, whereby the combined effect of two or more pathogens exceeds the sum of their individual effects, is a central theme in the pathogenesis of feline gastroenteritis. FAstV is rarely found in isolation; instead, it is commonly detected alongside a suite of other enteric viruses, including feline panleukopenia virus (FPV), feline bocavirus (FBoV), feline kobuvirus (FeKoV), feline coronavirus (FCoV), and rotavirus [1, 4, 18, 19, 23]. The prevalence of co-infection is remarkably high. One comprehensive study in Guangxi, China, found that 39.4% (13/33) of FAstV-positive samples were co-infected with at least one other major enteric virus [1]. This finding is consistent with other reports, where mixed infections were identified in 38 out of 46 FAstV-positive samples [4], and a multiplex PCR study in northeast China revealed a total enteric virus positive rate of 59.89% (118/197), with FPV, FBoV, and FAstV detected in 73, 51, and 46 samples, respectively, with substantial overlap [18].

The Predominant Synergy: FAstV and Feline Panleukopenia Virus (FPV)

Among all co-infection combinations, the FAstV-FPV pairing is the most frequently identified and the most clinically consequential. Multiple independent studies have converged on this finding. In the Guangxi study, FAstV-FPV co-infection was the predominant viral combination, accounting for 27.27% (9/33) of all FAstV-positive cases [1]. Similarly, in a study focusing on FAstV isolation, the majority of positive diarrheal samples were co-infected with FPV [2]. This association is not merely epidemiological; it has a profound biological basis that drives synergistic pathogenesis.

The mechanism of this synergy is rooted in the distinct but complementary pathogenic strategies of the two viruses. FPV, a highly virulent parvovirus, is characterized by its tropism for rapidly dividing cells, including intestinal crypt epithelial cells and hematopoietic progenitor cells. FPV infection causes severe enteritis, villous atrophy, and profound immunosuppression due to panleukopenia. This immunosuppression is the critical enabler. By depleting lymphocytes and impairing both humoral and cell-mediated immune responses, FPV creates a permissive environment for secondary pathogens. In this context, FAstV, which is typically controlled by a robust innate and adaptive immune response, can replicate to much higher titers. Experimental co-infection studies have provided direct evidence for this, demonstrating that FAstV replication is significantly enhanced in the presence of FPV [2]. The FPV-induced damage to the intestinal epithelium also compromises the mucosal barrier, facilitating FAstV invasion of enterocytes and exacerbating the resulting enteritis. Conversely, FAstV-induced damage to the intestinal epithelium may further impair the host’s ability to regenerate crypt cells, compounding the FPV-induced villous atrophy and leading to more severe, prolonged, and potentially fatal gastroenteritis. This bidirectional amplification of pathology explains why co-infected cats often present with more severe clinical signs, including hemorrhagic diarrhea, profound dehydration, and higher mortality rates, compared to those infected with either virus alone.

Other Significant Co-infections and Their Implications

While FAstV-FPV is the most prominent, other co-infection combinations are also clinically significant. FAstV is frequently found alongside FBoV, FeKoV, and FCoV [4, 18, 19]. The clinical implications of these combinations are less well-defined than the FAstV-FPV synergy, but they are nonetheless important. FBoV, a parvovirus, can also cause enteritis and immunosuppression, potentially acting through similar mechanisms to FPV. FeKoV, another emerging enteric virus, is associated with gastroenteritis, and its co-occurrence with FAstV likely contributes to an additive or synergistic burden on the intestinal tract. The development of advanced diagnostic tools, such as quadruplex RT-qPCR assays capable of simultaneously detecting FeKoV, FAstV, FeBuV, and FRV [17], and multiplex PCR methods for FPV, FBoV, and FAstV [18], has been instrumental in uncovering the true prevalence of these mixed infections. These tools have revealed that co-infection rates can be exceptionally high, with one study reporting a 25.19% (34/135) total rate of co-infection among FBoV-1, FeAstV, FeKoV, and FPV, and even a 1.48% (2/135) rate of quadruple infection [23]. The presence of multiple pathogens complicates the clinical picture, making it difficult to attribute specific signs to a single agent and underscoring the need for comprehensive diagnostic panels.

Epidemiological and Environmental Context

The prevalence and clinical impact of FAstV and its co-infections are not uniform across all cat populations. Epidemiological studies have identified key risk factors that influence infection dynamics. Age is a critical determinant, with kittens and juvenile cats under one year of age showing significantly higher FAstV detection rates. In a study from Japan, the detection rate in cats under one year was 27.8%, compared to 12.4% in older cats [9]. This age predisposition is likely due to the immaturity of the adaptive immune system in young animals, making them more susceptible to primary infection and severe disease. Seasonality also plays a role, with FAstV detection rates significantly higher in winter (44.4%) compared to other seasons in the same Japanese study [9], a pattern observed for other astroviruses in human populations and environmental waters [12]. This may be related to increased indoor crowding, reduced ventilation, and environmental stability of the virus at lower temperatures.

The environment in which cats are housed is a major driver of transmission and co-infection risk. Shelters, catteries, and multi-cat households are high-risk settings due to high population density, stress, and frequent introduction of new animals. The aforementioned outbreak of FAstV-associated vomiting in an animal shelter is a prime example of how the virus can rapidly spread and cause significant morbidity in such environments [7]. The role of urban wildlife as a reservoir for FAstV is an emerging concern. A virome study in bobcats (Lynx rufus) at the wildland-urban interface detected feline astrovirus, indicating that cross-species transmission between domestic and wild felids is occurring [10]. This finding has implications for the maintenance and potential evolution of the virus in the environment, as wild felids can act as a sylvatic reservoir, potentially reintroducing the virus into domestic populations and facilitating the emergence of novel strains. The co-circulation of FAstV in both domestic and wild felids underscores the need for a One Health approach to surveillance and control, recognizing the interconnectedness of animal and human health, as emphasized by organizations such as the World Organisation for Animal Health (WOAH).

Diagnostic and Clinical Management Implications

The high prevalence of asymptomatic shedding and the ubiquitous nature of co-infections present significant challenges for the clinician. A diagnosis of FAstV infection based solely on clinical signs is unreliable. The presence of diarrhea or vomiting in a cat is a non-specific finding that could be attributable to any number of viral, bacterial, parasitic, or dietary causes. Therefore, definitive diagnosis relies on molecular detection, with real-time RT-PCR (qPCR) being the gold standard due to its superior sensitivity and specificity compared to conventional RT-PCR [3, 5]. The development of multiplex assays is particularly valuable, as they allow for the simultaneous detection of FAstV and its most common co-pathogens (FPV, FBoV, FeKoV, FCoV) in a single reaction, providing a comprehensive etiological picture [17-19, 23]. This is critical for guiding appropriate therapy; for instance, a cat with FAstV alone may only require supportive care, whereas a cat co-infected with FPV requires aggressive antiviral therapy, passive immunization, and intensive supportive care to address the severe panleukopenia and enteritis.

In conclusion, the clinical manifestations of FAstV infection are highly variable, ranging from asymptomatic carriage to acute, self-limiting gastroenteritis. The severity of disease is profoundly influenced by the host’s age and immune status, but the single most important determinant is the presence of co-infecting pathogens, particularly FPV. The synergistic interaction between FAstV and FPV, driven by FPV-induced immunosuppression and intestinal damage, leads to enhanced viral replication and exacerbated pathology. This understanding has direct clinical relevance, emphasizing the need for comprehensive diagnostic testing using multiplex molecular panels to identify all co-infecting agents, thereby enabling targeted and effective therapeutic interventions. The high prevalence of FAstV in both healthy and diseased cats, its ability to cause outbreaks in shelter environments, and its detection in wildlife reservoirs highlight its importance as a pathogen that requires ongoing surveillance and a nuanced clinical approach.

Diagnostic Methods and Molecular Detection

The development and refinement of diagnostic modalities for Feline Astrovirus (FAstV) have progressed substantially from initial reliance on morphological identification to a sophisticated armamentarium of molecular techniques capable of high-throughput, multiplex, and quantitative detection. The diagnostic landscape for FAstV is uniquely challenged by the virus’s pronounced genetic heterogeneity, its frequent occurrence in mixed infections with other enteric pathogens, and the broad clinical spectrum ranging from asymptomatic shedding to acute gastroenteritis. Given that FAstV is an RNA virus with an error-prone RNA-dependent RNA polymerase (RdRp) and a demonstrated capacity for recombination, diagnostic strategies must be robust enough to detect divergent strains across multiple genogroups while maintaining the specificity required to discriminate FAstV from other mamastroviruses and enteric viruses [4, 15, 16]. This section provides an exhaustive examination of currently available diagnostic methods, from conventional and real-time PCR platforms to viral isolation, electron microscopy, and next-generation sequencing (NGS) approaches, with critical evaluation of their respective strengths, limitations, and optimal applications in clinical and research settings.

Molecular Detection Methods: An Overview of Conventional and Real-Time PCR

Conventional Reverse Transcription Polymerase Chain Reaction (RT-PCR) has served as the cornerstone for FAstV detection in epidemiological surveys and initial molecular characterization. Targeting conserved regions of the viral genome is paramount to ensure broad reactivity across circulating strains. The most frequently employed targets include the RdRp gene (located within ORF1b) and the capsid-encoding ORF2 gene, each offering distinct advantages. The RdRp gene is relatively conserved among astroviruses, making it suitable for generic detection and phylogenetic placement, while ORF2 exhibits greater variability, enabling genogroup differentiation and strain-level characterization [4, 16]. Seminal studies in China utilized RdRp-targeted RT-PCR to establish the first prevalence data in mainland China, detecting FAstV in 23.4% of sampled cats and revealing significant genetic diversity that formed the basis for the current two-genogroup classification system [4]. The sensitivity of conventional RT-PCR is generally moderate, with detection limits reported around 10³–10⁴ copies/μL depending on primer design and reaction conditions [19]. However, this method is limited by its inability to provide quantitative data, its reliance on post-amplification gel electrophoresis, and its comparatively lower sensitivity relative to real-time platforms, which can miss low-copy-number infections that may be clinically relevant, particularly in asymptomatic carriers or early-stage disease.

Real-Time Quantitative RT-PCR has supplanted conventional RT-PCR as the preferred method for FAstV detection due to superior sensitivity, quantitative capability, and reduced risk of amplicon contamination. Two principal chemistries have been developed and validated for FAstV: SYBR Green I-based assays and TaqMan probe-based assays.

The SYBR Green I-based real-time RT-PCR assay, targeting the ORF1b gene, demonstrated a detection limit of 3.72 × 10¹ copies/μL, representing a 100-fold improvement over conventional RT-PCR, with excellent specificity showing no cross-reactivity with feline parvovirus (FPV), feline herpesvirus, feline calicivirus, feline bocavirus, or feline coronavirus [5]. Intra- and inter-assay coefficients of variation (CV) of less than 1% underscore the reproducibility of this approach, and its cost-effectiveness makes it particularly attractive for large-scale epidemiological screening [5]. However, SYBR Green assays are inherently susceptible to non-specific amplification and primer-dimer artifacts, necessitating meticulous primer design and melt curve analysis to ensure specificity.

The TaqMan probe-based real-time PCR represents the gold standard for quantitative FAstV detection due to its exceptional specificity conferred by the fluorogenic probe. Dong et al. developed a TaqMan qPCR targeting a conserved region of the FAstV genome, achieving a remarkable limit of detection of 3.52 copies/μL, approximately 1000-fold more sensitive than conventional PCR, with intra- and inter-assay CVs below 1.72% [3]. This assay demonstrated no cross-reactivity with a panel of feline pathogens, and its application to 578 clinical fecal samples revealed an overall prevalence of 18.17%, with a significantly higher positive rate in diarrheic cats (32.26%) compared to asymptomatic cats (7.58%), thereby providing compelling molecular evidence linking FAstV infection to clinical disease [3]. The quantitative nature of this assay also enables viral load monitoring, which is critical for understanding pathogenesis, transmission dynamics, and evaluating the efficacy of potential antiviral interventions.

A more recent advancement is the development of a quadruplex RT-qPCR capable of simultaneously detecting FAstV along with feline kobuvirus (FeKoV), feline bufavirus (FeBuV), and feline rotavirus (FRV) [17]. This assay, targeting the ORF2 gene of FAstV, demonstrated limits of detection of 115.834 copies/reaction for FAstV, with intra- and inter-assay CVs of 0.15–1.61% and 0.15–1.59%, respectively [17]. When applied to 1869 clinical samples from southern China, the assay yielded a FAstV positivity rate of 9.36% and demonstrated coincidence rates exceeding 98.7% with reference assays [17]. This multiplex approach is particularly valuable given the high frequency of co-infections documented in FAstV-positive animals; studies have consistently reported that 39.4% to 82.6% of FAstV-positive samples harbor at least one additional enteric virus, with FPV being the most common co-pathogen [1, 2, 4, 18, 20, 23]. The ability to detect multiple pathogens in a single reaction conserves valuable clinical samples, reduces turnaround time, and provides a more comprehensive diagnostic picture that is essential for understanding the complex etiology of feline gastroenteritis.

Multiplex PCR and Multiplex Real-Time RT-PCR for Simultaneous Pathogen Detection

The recognition that feline gastroenteritis rarely results from monoinfection has driven the development of multiplex PCR platforms that can detect and differentiate FAstV from other common enteric viruses. Zhang et al. established a conventional multiplex PCR (mPCR) assay that simultaneously targets the VP2 gene of FPV, the NP1 gene of feline bocavirus (FBoV), and the RdRp gene of FAstV, yielding amplicons of 237 bp, 465 bp, and 645 bp, respectively [18]. This assay demonstrated sensitivity of 2.25–4.04 × 10⁴ copies/μL for each target and 100% concordance with uniplex PCR when testing 197 clinical samples from northeast China, revealing co-infections in a substantial proportion of positive animals [18]. A similar approach by Xiao et al. expanded the multiplex capacity to include four intestinal pathogens (feline coronavirus, FAstV, FPV, and FeKoV) and five respiratory pathogens in two separate mPCR reactions, with detection limits of 10³ copies/μL for FAstV [19]. While these conventional multiplex assays are cost-effective and accessible for laboratories without real-time PCR capabilities, they lack quantitative data and may have reduced sensitivity compared to real-time multiplex formats.

The multiplex real-time PCR approach, as exemplified by the work of Zou et al., combines the high sensitivity of TaqMan probes with the throughput of multiplexing, achieving detection limits of 10 copies for single-target qPCR and 100 copies for the quadruplex format targeting FBoV-1, FAstV, FeKoV, and FPV [23]. This assay, when applied to 135 clinical samples, identified a 25.19% rate of co-infection among the four viruses, with quadruple infections detected in 1.48% of cases [23]. The high correlation coefficients (>0.995) across all targets underscore the assay's robustness for routine surveillance [23]. The incorporation of multiple fluorescent dyes with distinct emission spectra allows for real-time discrimination of each pathogen within a single reaction, providing both qualitative and quantitative data that is invaluable for clinical decision-making and epidemiological investigations.

Viral Isolation and Electron Microscopy

Despite the predominance of molecular methods, viral isolation in cell culture remains a critical tool for characterizing biological properties, assessing pathogenicity, and generating viral stocks for experimental studies. Historically, FAstV isolation has proven challenging due to the fastidious growth requirements of many astrovirus strains. However, recent advances have yielded successful isolation protocols. Xue et al. successfully isolated a novel FAstV strain (GXNNF10-2024) from Guangxi, China, using trypsin-supplemented feline kidney-derived FK81 cell cultures, observing characteristic cytopathic effects (CPEs) including cell rounding, detachment, and syncytia formation, with confirmation by RT-PCR and immunofluorescence [1]. Similarly, Wang et al. isolated strain 22SDWH1003-16 in F81 cells from a diarrheic cat, achieving stable CPEs over 15 serial passages, and demonstrated that this isolate belonged to Mamastrovirus 2 group 1, the most common genotype in cats [2]. The addition of trypsin to culture media is a critical factor, as astrovirus capsid proteins require proteolytic cleavage for infectivity, and this requirement mirrors the in vivo environment where trypsin-like proteases in the intestinal lumen facilitate viral entry [16]. The establishment of these culture systems provides essential tools for future studies on viral replication kinetics, antiviral susceptibility testing, and the generation of inactivated vaccines.

Electron microscopy (EM) played a pivotal role in the initial discovery of FAstV, with Marshall et al. first identifying 30 nm astrovirus particles in feline fecal samples in 1987 [14]. These particles exhibit the characteristic five- or six-pointed star-like surface morphology that gives the family Astroviridae its name. While EM provided the foundational visualization of the virus, it has limited diagnostic utility in contemporary practice due to its low sensitivity (requiring approximately 10⁶–10⁷ viral particles per gram of feces), high cost, requirement for specialized equipment and expertise, and inability to distinguish between morphologically similar enteric viruses or provide genotypic information [14]. Immune electron microscopy (IEM), utilizing virus-specific antisera to aggregate particles and enhance detection, can improve sensitivity and provide serotype identification, but this technique is now largely of historical interest, having been supplanted by molecular methods.

Next-Generation Sequencing and Metagenomics

The advent of next-generation sequencing (NGS) and viral metagenomics has revolutionized the discovery and characterization of novel FAstV strains and provided unprecedented insights into the fecal virome of felines. These unbiased, sequence-independent approaches enable the detection of both known and divergent viruses without a priori knowledge of their sequences, making them particularly valuable for identifying emerging pathogens and characterizing the complete genetic diversity of the astrovirus family. Brussel et al. employed metagenomic NGS of viral nucleic acids from feline fecal samples to identify two novel astroviruses, designated Feline astrovirus 3 and 4, which shared the canonical three open reading frame (ORF) genome organization but were phylogenetically distinct from previously described feline astroviruses [13]. One of these novel viruses was isolated from a healthy shelter-housed kitten, while the other was identified in a kitten with diarrhea co-infected with FPV, underscoring the complexity of associating astrovirus detection with clinical disease [13].

The application of NGS in outbreak settings has proven instrumental in establishing causal relationships. During an outbreak of vomiting in an animal shelter where routine testing for known enteric pathogens failed to identify an etiology, viral metagenomics on four mini-pools of fecal samples revealed the presence of FAstV in all pools, while other viruses (rotavirus, bocaparvovirus, norovirus, and a dependovirus) were found at much lower prevalence and read counts [7]. Longitudinal real-time RT-PCR confirmed that 91% of sick cats shed astrovirus for up to 19 days, while only 56% of unaffected control cats were shedding, and screening of samples collected one year before and after the outbreak showed no astrovirus shedding, temporally implicating FAstV as the causative agent of the vomiting outbreak [7]. This study elegantly demonstrates how NGS can rapidly identify an etiological agent when targeted diagnostics fail, and how it can be combined with quantitative follow-up assays to strengthen causal inference.

Furthermore, Hata et al. utilized next-generation amplicon sequencing to characterize astrovirus strains in environmental water samples, collaterally identifying feline astrovirus strains and providing evidence of recombination between human and feline astroviruses [12]. This finding has significant implications for understanding cross-species transmission and the emergence of novel recombinant strains, as astroviruses are known to have high recombination rates due to their segmented-like replication strategy involving template switching during RNA synthesis [12, 15]. The capacity of NGS to detect recombinant viruses that may evade detection by conventional PCR assays targeting conserved regions underscores the importance of integrating metagenomic surveillance into routine diagnostic workflows.

Diagnostic Challenges and Considerations for Clinical Implementation

Despite the availability of highly sensitive and specific molecular assays, several challenges complicate FAstV diagnosis in clinical practice. The high genetic diversity among FAstV strains, with mean amino acid p-distances of 0.445–0.765 between genogroups [1], necessitates careful primer and probe design to ensure detection of all circulating genotypes. Assays targeting highly conserved regions, such as the RdRp gene [4, 5, 18, 19], are less likely to miss divergent strains compared to those targeting the more variable ORF2 capsid gene. However, ORF2-targeted assays provide superior genotyping resolution and are essential for molecular epidemiological tracking [1, 3, 9, 17].

Frequent co-infections pose another diagnostic challenge, as the clinical signs of FAstV infection (vomiting, diarrhea, dehydration) are indistinguishable from those caused by FPV, FCoV, FBoV, FeKoV, and other enteric pathogens [1, 2, 18, 20, 23, 24]. The use of multiplex assays that simultaneously screen for multiple pathogens is therefore strongly recommended to avoid diagnostic tunneling and to provide a complete etiological picture. This is particularly important given evidence that co-infections, especially with FPV, may enhance FAstV replication and disease severity, suggesting a synergistic pathogenic mechanism [2].

Sample type and timing are critical considerations. Fecal samples are the specimen of choice for FAstV detection, as the virus is shed in high concentrations in feces during acute infection. However, viral shedding can be intermittent, and asymptomatic cats may shed virus at levels below the detection limit of conventional RT-PCR [7, 14]. The superior sensitivity of real-time qPCR is therefore essential for detecting low-copy-number infections [3, 5]. Rectal swabs are a practical alternative for sample collection, particularly in shelter or field settings, although they may yield lower viral loads compared to bulk feces [26]. The use of vomit samples for PCR detection has been evaluated for FPV with promising results [26], but its utility for FAstV detection remains to be systematically assessed.

Point-of-care testing for FAstV is not currently available, and the diagnosis of FAstV infection remains reliant on laboratory-based molecular methods. In contrast to FPV, for which ELISA-based point-of-care tests are widely used in shelter settings [26], no commercial rapid antigen test exists for FAstV. The development of such tests, perhaps based on monoclonal antibodies directed against conserved capsid epitopes, would be a valuable addition to the diagnostic armamentarium, particularly for rapid outbreak investigations and resource-limited settings.

Finally, the interpretation of positive results must be made in the context of clinical signs and the detection of other pathogens, given the high rate of asymptomatic FAstV shedding [4, 7, 14]. Quantitative viral load data from real-time PCR can aid in distinguishing active infection from incidental shedding, as higher viral loads are generally associated with clinical disease [3]. The establishment of clinically relevant viral load thresholds, analogous to those used for FIP diagnosis [25], would further enhance the diagnostic utility of real-time PCR for FAstV and support evidence-based clinical decision-making.

Virus Isolation, Cell Culture, and In Vitro Characterization

The successful isolation and in vitro propagation of feline astrovirus (FAstV) represent a critical cornerstone for advancing our understanding of its biology, pathogenesis, and evolutionary dynamics. Despite the widespread molecular detection of FAstV in feline populations globally, the establishment of robust cell culture systems has historically lagged behind, presenting a significant bottleneck for functional studies. The inherent challenges in cultivating these fastidious enteric viruses, coupled with their frequent co-occurrence with other pathogens and the lack of standardized protocols, have only recently begun to be systematically addressed. This section provides an exhaustive analysis of the methodologies, biological underpinnings, and implications of FAstV isolation, cell culture adaptation, and subsequent in vitro characterization, drawing upon the most recent and seminal studies in the field.

Primary Isolation and Cell Line Susceptibility

The cornerstone of FAstV isolation lies in the selection of permissive cell lines and the optimization of culture conditions, particularly the supplementation of proteolytic enzymes. Historically, the isolation of astroviruses from various species has been notoriously difficult, often requiring the use of primary cells or specific continuous cell lines with added trypsin to cleave the viral capsid protein, a prerequisite for infectivity [16, 22]. For FAstV, the feline kidney-derived cell lines, specifically FK81 and F81, have emerged as the most reliable substrates for primary isolation.

Pioneering work by Xue et al. (2025) demonstrated the successful isolation of a novel FAstV strain, GXNNF10-2024, from a domestic cat in Guangxi, China, using FK81 cells maintained in a medium supplemented with trypsin [1]. This study meticulously documented the development of characteristic cytopathic effects (CPEs), which were confirmed as virus-specific through RT-PCR and immunofluorescence assays (IFA). The requirement for trypsin is a critical mechanistic detail; astrovirus capsid proteins are synthesized as a single polyprotein that must undergo extracellular proteolytic cleavage by trypsin-like proteases to generate mature, infectious virions [16]. The addition of trypsin to the culture medium mimics the proteolytic environment of the feline intestinal tract, thereby facilitating the multi-round replication necessary for visible CPE development. Similarly, Wang et al. (2025) successfully isolated strain 22SDWH1003-16 from a diarrheic cat in China using F81 cells, observing CPE over 15 serial passages [2]. The sustained production of CPE across multiple passages indicates that the virus had successfully adapted to the in vitro environment, a hallmark of a successfully isolated and cultured virus. The consistent use of FK81 and F81 cells across these independent studies underscores their superior susceptibility to FAstV, likely due to the expression of specific host cell receptors or proteases that are compatible with the viral life cycle.

The biological rationale for this cell line tropism is multifaceted. F81 cells, being a continuous line derived from feline kidney, retain the cellular machinery necessary for astrovirus replication, including the ability to support viral RNA-dependent RNA polymerase (RdRp) activity and capsid protein synthesis. The requirement for trypsin, however, is not merely a technical convenience but a reflection of the virus's evolutionary adaptation to the gastrointestinal environment. In vivo, astrovirus particles encounter a cascade of host proteases in the stomach and small intestine, which process the capsid spike domain, exposing the receptor-binding sites and enabling entry into enterocytes [16]. In vitro, the absence of this natural proteolytic environment necessitates exogenous supplementation. The concentration and source of trypsin are therefore critical variables; excessive trypsin can degrade viral particles, while insufficient levels fail to activate the virus, explaining the fastidious nature of primary isolation.

Cytopathic Effect and Viral Confirmation

The characterization of CPE is a fundamental step in confirming successful viral isolation and assessing the kinetics of viral replication. For FAstV, the CPE in FK81 and F81 cells is typically described as focal rounding, detachment, and eventual lysis of the cell monolayer, although the progression can be subtle and slow compared to more cytopathic viruses like feline parvovirus [1, 2]. The initial appearance of CPE may require several days post-inoculation and multiple blind passages before becoming consistently observable. This delayed onset is characteristic of many astroviruses and is attributed to their relatively slow replication cycle and the need for capsid maturation.

Confirmation of the isolated virus as FAstV relies on a combination of molecular and immunological techniques. RT-PCR targeting the conserved ORF1b (RdRp) or ORF2 (capsid) genes is the primary method for detecting viral RNA in cell culture supernatants or lysates [1-3, 18]. The high sensitivity of real-time RT-PCR assays, such as those developed by Dong et al. (2021) with a limit of detection of 3.52 copies/μL, allows for the quantification of viral RNA even in the early stages of infection when CPE may not be apparent [3]. Immunofluorescence assays (IFA) using polyclonal or monoclonal antibodies against the FAstV capsid protein provide direct visual evidence of viral antigen within infected cells, confirming that the observed CPE is indeed due to viral replication and not a toxic effect of the inoculum [1]. The combination of these techniques ensures the specificity of the isolation, distinguishing FAstV from other enteric viruses that may be present in the original clinical sample, such as feline parvovirus (FPV), feline bocavirus (FBoV), or feline kobuvirus (FeKoV) [1, 2, 4, 20, 27].

In Vitro Growth Kinetics and Characterization

Once a stable isolate is established, a comprehensive in vitro characterization is essential to define its biological properties. This includes determining the one-step growth curve, which measures the kinetics of viral RNA replication and progeny virion production over a single replication cycle. Such studies reveal the eclipse phase, the exponential replication phase, and the plateau phase, providing insights into the virus's replication efficiency and burst size. For FAstV, these parameters are still being elucidated, but preliminary data suggest a relatively slow replication cycle, with peak titers often not reached until 48-72 hours post-infection [2]. This contrasts with more rapidly replicating enteric viruses and may have implications for the pathogenesis of FAstV infections, particularly in the context of co-infections.

The role of co-infection, particularly with FPV, is a critical area of investigation that can be modeled in vitro. Epidemiological studies have consistently shown that FAstV is frequently detected in cats co-infected with FPV, suggesting a potential synergistic interaction [1, 2, 4, 20]. Wang et al. (2025) provided direct experimental evidence for this phenomenon by demonstrating enhanced FAstV replication in F81 cells when co-infected with FPV [2]. The mechanistic basis for this enhancement is likely multifactorial. FPV, a parvovirus, is highly cytopathic and causes significant damage to the intestinal epithelium and lymphoid tissues, potentially creating a more permissive environment for FAstV replication. Alternatively, FPV infection may suppress the host's innate antiviral immune responses, such as the interferon pathway, thereby removing a key barrier to astrovirus replication. In vitro co-infection models are invaluable for dissecting these interactions, allowing researchers to quantify viral RNA levels of each virus separately using specific RT-qPCR assays and to observe the temporal dynamics of co-infection at the single-cell level using multiplex IFA.

Furthermore, in vitro systems are indispensable for evaluating the antigenic properties of FAstV isolates. Neutralization assays, using polyclonal sera from infected or vaccinated cats, can determine the serological relatedness of different FAstV strains. This is particularly relevant given the significant genetic diversity observed among FAstV isolates, which have been classified into multiple genogroups (G1-G3) based on ORF2 capsid gene sequences [1, 4]. The capsid protein is the primary target of neutralizing antibodies [16], and significant amino acid divergence (p-distance of 0.445-0.765) between genogroups suggests that they may represent distinct serotypes [1]. Cross-neutralization studies using in vitro cell culture systems are essential to test this hypothesis. If different genogroups are serologically distinct, it would have profound implications for the development of effective vaccines and diagnostic serological assays, as a vaccine based on one genogroup may not protect against another.

Finally, the availability of infectious FAstV isolates is a prerequisite for antiviral drug screening. The development of effective antiviral compounds against feline enteric viruses is an area of active research, particularly given the lack of specific treatments for FAstV infection. In vitro assays using cell culture-adapted FAstV strains can be used to screen libraries of compounds for their ability to inhibit viral replication, as has been done for feline coronavirus (FIPV) [28]. Such assays typically involve infecting cell monolayers in the presence of serial dilutions of a candidate drug, followed by quantification of viral RNA or CPE reduction to calculate the half-maximal effective concentration (EC50). The establishment of a robust and reproducible in vitro system for FAstV, as achieved by Xue et al. and Wang et al., now provides the essential platform for these downstream applications, bridging the gap between molecular detection and functional virology [1, 2].

References

[1] Xue R, Wang R, Zhang H, Xu W, Liu Y, Cao D, et al.. Genetic characterization and isolation of feline astrovirus in domestic cats in Guangxi, China.. Virology. 2025. DOI: https://doi.org/10.1016/j.virol.2025.110774

[2] Wang W, Zhang Y, Wang X, Zhu X, Gong L, Jing Z, et al.. Isolation and preliminary pathogenicity of a recent feline astrovirus strain in China. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1614686

[3] Dong G, Wang Q, Niu J, Cai Y, Guo Y, Zhao H, et al.. Development and application of a TaqMan-based real-time PCR assay for specifically detecting feline astrovirus.. Molecular and Cellular Probes. 2021. DOI: https://doi.org/10.1016/j.mcp.2021.101729

[4] Yi S, Niu J, Wang H, Dong G, Guo Y, Dong H, et al.. Molecular characterization of feline astrovirus in domestic cats from Northeast China. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0205441

[5] Wang Y, Fu Z, Guo X, Zhang D, Bai C, Li W, et al.. Development of SYBR Green I-based Real-time Reverse Transcription Polymerase Chain Reaction for the Detection of Feline Astrovirus.. Journal of Virological Methods. 2020. DOI: https://doi.org/10.1016/j.jviromet.2020.114012

[6] Lau S, Woo P, Yip CCY, Bai R, Wu Y, Tse H, et al.. Complete Genome Sequence of a Novel Feline Astrovirus from a Domestic Cat in Hong Kong. Genome Announcements. 2013. DOI: https://doi.org/10.1128/genomeA.00708-13

[7] Li Y, Gordon E, Idle A, Hui A, Chan RY, Seguin M, et al.. Astrovirus Outbreak in an Animal Shelter Associated With Feline Vomiting. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.628082

[8] Thaw YN, Charoenkul K, Nasamran C, Chamsai E, Jairak W, Phyu EM, et al.. Monitoring and characterization of canine and feline astroviruses in domestic dogs and cats in Thailand. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-03037-0

[9] Soma T, Ogata M, Ohta K, Yamashita R, Sasai K. Prevalence of astrovirus and parvovirus in Japanese domestic cats. Journal of Veterinary Medical Science. 2020. DOI: https://doi.org/10.1292/jvms.20-0205

[10] Payne N, Andersen D, Mollohan C, Doorslaer Kv, Combrink L, Culver M. Urbanisation and Host Relatedness Shape Virome Composition in a Widespread, Generalist Carnivore. Molecular Ecology. 2025. DOI: https://doi.org/10.1111/mec.17681

[11] Toffan A, Jonassen C, Battisti CD, Schiavon E, Kofstad T, Capua I, et al.. Genetic characterization of a new astrovirus detected in dogs suffering from diarrhoea. Veterinary Microbiology. 2009. DOI: https://doi.org/10.1016/j.vetmic.2009.04.031

[12] Hata A, Kitajima M, Haramoto E, Lee S, Ihara M, Gerba C, et al.. Next-generation amplicon sequencing identifies genetically diverse human astroviruses, including recombinant strains, in environmental waters. Scientific Reports. 2018. DOI: https://doi.org/10.1038/s41598-018-30217-y

[13] Brussel KV, Wang X, Shi M, Carrai M, Li J, Martella V, et al.. Identification of Novel Astroviruses in the Gastrointestinal Tract of Domestic Cats. Viruses. 2020. DOI: https://doi.org/10.3390/v12111301

[14] Marshall J, Kennett M, Rodger S, Studdert M, Thompson W, Gust I. Virus and virus‐like particles in the faeces of cats with and without diarrhoea. Australian Veterinary Journal. 1987. DOI: https://doi.org/10.1111/j.1751-0813.1987.tb09638.x

[15] Wohlgemuth N, Honce R, Schultz‐Cherry S. Astrovirus evolution and emergence. Infection, Genetics and Evolution. 2019. DOI: https://doi.org/10.1016/j.meegid.2019.01.009

[16] Arias C, DuBois R. The Astrovirus Capsid: A Review. Viruses. 2017. DOI: https://doi.org/10.3390/v9010015

[17] Shi K, He M, Long F, He J, Yin Y, Feng S, et al.. Development of a Quadruplex RT-qPCR for the Detection of Feline Kobuvirus, Feline Astrovirus, Feline Bufavirus, and Feline Rotavirus. Microbiology Research. 2024. DOI: https://doi.org/10.3390/microbiolres15040143

[18] Zhang Q, Niu J, Yi S, Dong G, Yu D, Guo Y, et al.. Development and application of a multiplex PCR method for the simultaneous detection and differentiation of feline panleukopenia virus, feline bocavirus, and feline astrovirus. Archives of Virology. 2019. DOI: https://doi.org/10.1007/s00705-019-04394-8

[19] Xiao X, Hao X, Chen B, Zhou P, Li S. Two Multiplex PCR Methods for Detecting Several Pathogens Associated with Feline Respiratory and Intestinal Tracts. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci10010014

[20] Wang J, Yan Z, Liu H, Wang W, Liu Y, Zhu X, et al.. Prevalence and Molecular Evolution of Parvovirus in Cats in Eastern Shandong, China, between 2021 and 2022. Transboundary and Emerging Diseases. 2024. DOI: https://doi.org/10.1155/2024/5514806

[21] Vu D, Bosch A, Pintó R, Guix S. Epidemiology of Classic and Novel Human Astrovirus: Gastroenteritis and Beyond. Viruses. 2017. DOI: https://doi.org/10.3390/v9020033

[22] Johnson CN, Hargest V, Cortez V, Meliopoulos VA, Schultz‐Cherry S. Astrovirus Pathogenesis. Viruses. 2017. DOI: https://doi.org/10.3390/v9010022

[23] Zou J, Yu J, Mu Y, Xie X, Wang R, Wu H, et al.. Development of a TaqMan-based multiplex real-time PCR for simultaneous detection of four feline diarrhea-associated viruses. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.1005759

[24] Putri R, Wahyuwardani S. Koinfeksi pada Kejadian Panleukopenia Kucing: Suatu Kajian Pustaka. Jurnal Veteriner. 2022. DOI: https://doi.org/10.19087/jveteriner.2022.23.1.121

[25] Thayer V, Gogolski SM, Felten S, Hartmann K, Kennedy M, Olah G. 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines. Journal of feline medicine and surgery. 2022. DOI: https://doi.org/10.1177/1098612X221118761

[26] Jacobson L, Janke KJ, Giacinti J, Weese J. Diagnostic testing for feline panleukopenia in a shelter setting: a prospective, observational study. Journal of feline medicine and surgery. 2021. DOI: https://doi.org/10.1177/1098612X211005301

[27] Deng B, Song Y, Li L, Zhou Y, Zhu C, Zhang W, et al.. Detection and genetic characterization of canine kobuvirus from stray dogs in Shanghai, China. Archives of Virology. 2023. DOI: https://doi.org/10.1007/s00705-023-05710-z

[28] Cook SE, Vogel H, Castillo D, Olsen M, Pedersen N, Murphy B. Investigation of monotherapy and combined anticoronaviral therapies against feline coronavirus serotype II in vitro. Journal of feline medicine and surgery. 2021. DOI: https://doi.org/10.1177/1098612X211048647